• 1
    Etten EV, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005; 97:93101.
  • 2
    Ebert R, Schütze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol 2006; 248:14959.
  • 3
    Laaksi I, Ruohola J-P, Tuohimaa P et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007; 86:71417.
  • 4
    Baeke F, Ev E, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol Aspects Med 2008; 29:37687.
  • 5
    Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87:1080S6S.
  • 6
    Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85:8608.
  • 7
    Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:26681.
  • 8
    Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167:17307.
  • 9
    Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest 2005; 128:37928.
  • 10
    Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98:68005.
  • 11
    D'Ambroxio DCM, Cocciolo MG, Mazzeo D et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101:25262.
  • 12
    Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4:8090.
  • 13
    Adams JS, Chen H, Chun R et al. Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J Bone Miner Res 2007; 22 (Suppl. 2):V204.
  • 14
    Berry DM, Clark CS, Meckling-Gill KA. 1,25-Dihydroxyvitamin D3 stimulates phosphorylation of IkB and synergizes with TPA to induce nuclear translocation of NF-kB during monocytic differentiation of NB4 leukemia cells. Exp Cell Res 2002; 272:17684.
  • 15
    Tse AK-W, Wan C-K, Shen X-L et al. 1,25-Dihydroxyvitamin D3 induces biphasic NF-kB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkB. Exp Cell Res 2007; 313:172234.
  • 16
    Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 48:2712.
  • 17
    Hyppönen E, Läärä E, Reunanen A, Järvelin M-R, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358:15003.
  • 18
    Szodoray P, Nakken B, Gaal J et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008; 68:2619.
  • 19
    Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008; 181:70909.
  • 20
    Liu PT, Modlin RL. Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol 2008; 20:3716.
  • 21
    Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37:11319.
  • 22
    Nursyam EWAZ, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006; 38:35.
  • 23
    Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:17703.
  • 24
    Martineau AR, Wilkinson RJ, Wilkinson KA et al. A single dose of vitamin D enhances immunity to Mycobacteria. Am J Respir Crit Care Med 2007; 176:20813.
  • 25
    Ralph AP, Kelly PM, Anstey NM. L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol 2008; 16:33644.
  • 26
    Krutzik SR, Hewison M, Liu PT et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 2008; 181:711520.
  • 27
    Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol 2000; 74:10916.
  • 28
    Cannell JJ, Vieth R, Umhau JC et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134:112940.
  • 29
    Najada AS, Habashneh MS, Khader M. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases. J Trop Pediatr 2004; 50:3648.
  • 30
    Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-dydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169:38490.
  • 31
    Stephenson A, Brotherwood M, Robert R, Atenafu E, Corey M, Tullis E. Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr 2007; 85:130711.
  • 32
    Chandra P, Wolfenden LL, Ziegler TR et al. Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes: a case series. Photodermatol Photoimmunol Photomed 2007; 23:17985.
  • 33
    Speeckaert M, Huang G, Delanghe JR, Taes YEC. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006; 372:3342.
  • 34
    Speeckaert MM, Wehlou C, Vandewalle S, Taes YE, Robberecht E, Delanghe JR. Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients. Clin Chem Lab Med 2008; 46:36570.
  • 35
    Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3. J Cyst Fibros 2007; 6:40310.
  • 36
    Kuebler KK, Buchsel PC, Balkstra CR. Differentiating chronic obstructive pulmonary disease from asthma. J Am Acad Nurse Pract 2008; 20:44554.
  • 37
    Mercer PF, Shute JK, Bhowmik A, Donaldson GC, Wedzicha JA, Warner JA. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005; 6:151.
  • 38
    Li Y, Zhang Z, Xu Y, Xiong S, Ni W, Chen S. TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease. J Huazhong Univ Sci Technolog Med Sci 2006; 26:64750.
  • 39
    Lim SAM, Roche N, Oliver BG, Mattos W, Barnes PJ, Fan Chung K. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers regulation by interleukin-10. Am J Respir Crit Care Med 2000; 162:135560.
  • 40
    Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002; 13:18794.
  • 41
    Hopkinson NS, Li KW, Kehoe A et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 2008; 87:38590.
  • 42
    Song Y, Qi H, Wu C. Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology 2007; 12:48694.
  • 43
    Burns JSDD, Speizer FE. Low levels of dietary vitamin D intake and pulmonary function in adolescents (abstract). Proc Am Thoracic Soc 2006; 3:A536.
  • 44
    Camargo CA, Rifas-Shiman SL, Litonjua AA et al. Prospective study of maternal intake of vitamin D during pregnancy and risk of wheezing illnesses in children at age 2 years. J Allergy Clin Immunol 2006; 117:7212.
  • 45
    Devereux G, Litonjua AA, Turner SW et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 2007; 85:8539.
  • 46
    Pichler J, Gerstmayr M, Szepfalusi Z, Urbanek R, Peterlik M, Willheim M. 1α,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 2002; 52:1218.
  • 47
    Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:9826.
  • 48
    Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373:190517.
  • 49
    Xystrakis E, Boswell S, Peek E et al. Reversing the defective induction of IL-10 secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006; 116:14655.